March 2018
New findings, published in the journal Alzheimer’s & Dementia — are thought to be the first to suggest that higher levels of branched-chain amino acids in a person’s blood could be a marker for a lower risk of developing dementia. After analysing data from eight large studies, researchers have identified certain molecules in the blood that might serve as early biomarkers for the risk of developing dementia and Alzheimer’s disease.